IL-9-producing type 2 innate lymphoid cells have been shown as the mediators of a molecular and cellular pathway that arranges the resolution of chronic inflammation in RA as evidenced by human and animal studies (23). The gene discussed is IL9; the disease is rheumatoid arthritis.